BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1029 related articles for article (PubMed ID: 29848239)

  • 1. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Finding the Optimal Age Cutoff for the UICC/AJCC TNM Staging System in Patients with Papillary or Follicular Thyroid Cancer.
    van Velsen EFS; Visser WE; Stegenga MT; Mäder U; Reiners C; van Kemenade FJ; van Ginhoven TM; Verburg FA; Peeters RP
    Thyroid; 2021 Jul; 31(7):1041-1049. PubMed ID: 33487121
    [No Abstract]   [Full Text] [Related]  

  • 3. Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts.
    Pontius LN; Oyekunle TO; Thomas SM; Stang MT; Scheri RP; Roman SA; Sosa JA
    Thyroid; 2017 Nov; 27(11):1408-1416. PubMed ID: 28891405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions.
    Tam S; Boonsripitayanon M; Amit M; Fellman BM; Li Y; Busaidy NL; Cabanillas ME; Dadu R; Sherman S; Waguespack SG; Williams MD; Goepfert RP; Gross ND; Perrier ND; Sturgis EM; Zafereo ME
    Thyroid; 2018 Oct; 28(10):1301-1310. PubMed ID: 30141373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort study.
    Kim M; Kim HI; Jeon MJ; Kim HK; Kim EH; Yi HS; Kim ES; Kim H; Kim BH; Kim TY; Kim SW; Kang HC; Kim WB; Chung JH; Shong YK; Kim TH; Kim WG
    Oral Oncol; 2018 Dec; 87():97-103. PubMed ID: 30527251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the prognostic value and N1b changes of the eighth TNM/AJCC staging system for differentiated thyroid carcinoma.
    Zhi J; Wu Y; Hu L; Zhao J; Liu H; Ruan X; Hou X; Zhang J; Zheng X; Gao M
    Int J Clin Oncol; 2020 Jan; 25(1):59-66. PubMed ID: 31414270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reassessment of Differentiated Thyroid Cancer Patients Using the Eighth TNM/AJCC Classification System: A Comparative Study.
    Shteinshnaider M; Muallem Kalmovich L; Koren S; Or K; Cantrell D; Benbassat C
    Thyroid; 2018 Feb; 28(2):201-209. PubMed ID: 29256827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the Seventh and Eighth Editions of the American Joint Committee on Cancer/Union for International Cancer Control Tumor-Node-Metastasis Staging System for Differentiated Thyroid Cancer.
    Kim M; Kim WG; Oh HS; Park S; Kwon H; Song DE; Kim TY; Shong YK; Kim WB; Sung TY; Jeon MJ
    Thyroid; 2017 Sep; 27(9):1149-1155. PubMed ID: 28635571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current TNM system of the UICC/AJCC : the prognostic significance for differentiated thyroid carcinoma].
    Stratmann M; Sekulla C; Dralle H; Brauckhoff M
    Chirurg; 2012 Jul; 83(7):646-51. PubMed ID: 22273853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the use of a two-step age-based cutoff for the UICC/AJCC TNM staging system in patients with papillary or follicular thyroid cancer.
    van Velsen EFS; Peeters RP; Stegenga MT; Mäder U; Reiners C; van Kemenade FJ; van Ginhoven TM; Visser WE; Verburg FA
    Eur J Endocrinol; 2022 Feb; 186(3):389-397. PubMed ID: 35038308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
    Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma.
    Kim TH; Kim YN; Kim HI; Park SY; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Kim K; Jeong JG; Kim SW; Chung JH
    Oral Oncol; 2017 Aug; 71():81-86. PubMed ID: 28688696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting recurrence of papillary thyroid cancer using the eighth edition of the AJCC/UICC staging system.
    Chereau N; Oyekunle TO; Zambeli-Ljepović A; Kazaure HS; Roman SA; Menegaux F; Sosa JA
    Br J Surg; 2019 Jun; 106(7):889-897. PubMed ID: 31012500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TUMOR SIZE IS AN INDEPENDENT PREDICTOR OF MORTALITY RISK IN DIFFERENTIATED THYROID CANCER PATIENTS WITH T4 DISEASE.
    Wang Z; Zhang Q; Ye H; Jia C; Lv Z; Liu J; Yin Z
    Endocr Pract; 2020 May; 26(5):499-507. PubMed ID: 31968190
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of survival rates between papillary and follicular thyroid carcinomas among 36,725 patients.
    Oyer SL; Fritsch VA; Lentsch EJ
    Ann Otol Rhinol Laryngol; 2014 Feb; 123(2):94-100. PubMed ID: 24574464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
    Lundgren CI; Hall P; Dickman PW; Zedenius J
    Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using the American Thyroid Association Risk-Stratification System to Refine and Individualize the American Joint Committee on Cancer Eighth Edition Disease-Specific Survival Estimates in Differentiated Thyroid Cancer.
    Ghaznavi SA; Ganly I; Shaha AR; English C; Wills J; Tuttle RM
    Thyroid; 2018 Oct; 28(10):1293-1300. PubMed ID: 29897011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.